Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Redbaron2211on Jan 15, 2019 6:03pm

60 Views

Post# 29236617

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:BIOTRUMP

Elgin, true was expecting to hear something from Viacyte on the VC-02 trial. There starting to make Sernova look speedy...

Anyways as data starts coming in from the sentinels at any point big pharma may feel this is derisked and we may see a partnership.

Investor fatigue is extreme but those who really take a step back and look around, these are very exciting times.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal